These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1374982)

  • 1. Epitopic mapping of linear and conformation-dependent antigenic determinants on GP5 of five U.S. bluetongue viruses.
    Yang YY; Johnson TM; Mecham JO; Tam JP; Li JK
    Virology; 1992 Jun; 188(2):530-6. PubMed ID: 1374982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of two immunodominant antigenic epitopes conserved among the major inner capsid protein, VP7 of five bluetongue viruses.
    Li JK; Yang YY
    Virology; 1990 Oct; 178(2):552-9. PubMed ID: 2171194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and localization of a serotypic neutralization determinant on the VP2 protein of bluetongue virus 13.
    Hwang GY; Li JK
    Virology; 1993 Aug; 195(2):859-62. PubMed ID: 7687805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformation of the VP2 protein of bluetongue virus (BTV) determines the involvement in virus neutralization of highly conserved epitopes within the BTV serogroup.
    White JR; Eaton BT
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1325-32. PubMed ID: 1693664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping and characterization of antigenic epitopes and the nucleic acid-binding domains of the VP6 protein of bluetongue viruses.
    Hayama E; Li JK
    J Virol; 1994 Jun; 68(6):3604-11. PubMed ID: 7514678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of antigenic epitopes of monoclonal antibodies against the VP2 protein of the 25 serotype of bluetongue virus.
    Xie S; Shi Y; Gong R; Cui W; Jiang Y; Liu M; Wang L; Zhou H; Qiao X; Li Y; Xu Y; Tang L
    Vet Microbiol; 2018 Jun; 219():136-143. PubMed ID: 29778186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine mapping of a surface-accessible, immunodominant site on the bluetongue virus major core protein VP7.
    Wang LF; Scanlon DB; Kattenbelt JA; Mecham JO; Eaton BT
    Virology; 1994 Nov; 204(2):811-4. PubMed ID: 7941351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a gene-targeted phage display random epitope library to map an antigenic determinant on the bluetongue virus outer capsid protein VP5.
    Wang LF; Du Plessis DH; White JR; Hyatt AD; Eaton BT
    J Immunol Methods; 1995 Jan; 178(1):1-12. PubMed ID: 7530266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing epitopes of the serotypes of bluetongue virus present in the United States.
    Rossitto PV; MacLachlan NJ
    J Gen Virol; 1992 Aug; 73 ( Pt 8)():1947-52. PubMed ID: 1379625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a neutralizing epitope shared by bluetongue virus serotypes 2 and 13.
    Ristow S; Leendersten L; Gorham J; Yilma T
    J Virol; 1988 Jul; 62(7):2502-4. PubMed ID: 2453681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic profile of African horse sickness virus serotype 4 VP5 and identification of a neutralizing epitope shared with bluetongue virus and epizootic hemorrhagic disease virus.
    Martínez-Torrecuadrada JL; Langeveld JP; Venteo A; Sanz A; Dalsgaard K; Hamilton WD; Meloen RH; Casal JI
    Virology; 1999 May; 257(2):449-59. PubMed ID: 10329555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amino acid sequence of the outer coat protein VP2 of neutralizing monoclonal antibody-resistant, virulent and attenuated bluetongue viruses.
    Gould AR; Eaton BT
    Virus Res; 1990 Nov; 17(3):161-72. PubMed ID: 1706548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic topography of bluetongue virus 17.
    Grieder FB; Schultz KT
    Microb Pathog; 1990 Apr; 8(4):299-303. PubMed ID: 1696679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel bluetongue virus 1-specific B-cell epitope using a monoclonal antibody against the VP2 protein.
    Wei P; Sun EC; Liu NH; Yang T; Xu QY; Zhao J; Qin YL; Feng YF; Li JP; Wang WS; Zhang CY; Wu DL
    Arch Virol; 2013 May; 158(5):1099-104. PubMed ID: 23292067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation of the major outer capsid protein of bluetongue viruses.
    Yang YY; Li JK
    Virology; 1993 May; 194(1):350-4. PubMed ID: 7683160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody analysis of serotype-restricted and unrestricted bluetongue viral antigenic determinants.
    Appleton JA; Letchworth GJ
    Virology; 1983 Jan; 124(2):286-99. PubMed ID: 6186076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to bluetongue virus define two neutralizing epitopes and a hemagglutinating epitope.
    Mecham JO; Jochim MM
    Viral Immunol; 1990; 3(2):161-70. PubMed ID: 1694430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of four distinct neutralizing epitopes on bluetongue virus serotype 10 using neutralizing monoclonal antibodies and neutralization-escape variants.
    Heidner HW; Rossitto PV; MacLachlan NJ
    Virology; 1990 Jun; 176(2):658-61. PubMed ID: 1693250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homotypic and heterotypic neutralization determinants of bluetongue virus serotype 17.
    Pierce CM; Rossitto PV; MacLachlan NJ
    Virology; 1995 May; 209(1):263-7. PubMed ID: 7538255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization determinants of United States bluetongue virus serotype ten.
    DeMaula CD; Heidner HW; Rossitto PV; Pierce CM; MacLachlan NJ
    Virology; 1993 Jul; 195(1):292-6. PubMed ID: 7686312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.